EY German Biotech Report Roadshow

​Germany stands at a defining moment for biotechnology.
The German Biotechnology Report 2026 shows why world‑class science alone is no longer enough—and how Germany can turn its research excellence, emerging technologies, and growing momentum into global biotech leadership. With a clear call to action, the report highlights what must change now for biotechnology to become a cornerstone of Germany’s economic resilience, innovation power, and sustainable growth.

​📋 Programme

​▸ Welcome — Opening remarks by Dr. Nicole Fehrenbacher, FUTURY (10 min)

​▸ Report — Presentation of the German EY Biotech Report by Klaus Ort (EY-Parthenon) with open discussion (until 17:00)

​▸ Panel — Expert panel discussion (until 18:00)

​Panel participants:

​· Consulting: Klaus Ort (EY-Parthenon)

​· Science: Prof. Dr. Michael Rossbach (Axiom-Insights)

​· Capital: Dr. Martin Raditsch (CARMA fund)

​· Industry: to be confirmed

​· Startup: Dr. Harald Pacl (Mitodicure)

​· Policy: to be confirmed

​▸ Networking reception (until 19:00)